Results 11 to 20 of about 312,011 (322)
Turkish Journal of Plastic Surgery, 2021 COVID-19 is a pandemic of unprecedented proportions in recent human history. Less than 18 months since the onset of the pandemic, there are close to two hundred million confirmed cases and four million deaths worldwide. There have also been massive efforts geared towards finding safe and effective vaccines.
Duduzile Ndwandwe, Charles S Wiysonge
+11 more sources
Covid-19 vaccination hesitancy [PDF]
BMJ, 2021 ### What you need to know Rollout of covid-19 vaccination is well underway, with more than 700 million doses given worldwide as of April 2021.1 Vaccination is highly effective at reducing severe illness and death from covid-19. Vaccines for covid-19 are also safe, with extremely low risks of severe adverse events.234 A major threat to the impact of ...
Razai, MS +4 more
openaire +7 more sources
Infectious Disease Clinics of North America, 2022 This article is a narrative review of the rapidly moving coronavirus disease 2019 vaccine field with an emphasis on clinical efficacy established in both randomized trials and postmarketing surveillance of clinically available vaccines. We review the major clinical trials that supported authorization for general use of the Janssen (Ad.26.CoV2), Pfizer ...
Hahn, William O., Wiley, Zanthia
openaire +4 more sources
Mandating COVID-19 Vaccines [PDF]
JAMA, 2021 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines hold promise to control the pandemic, and help restore normal social and economic life. The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for 2 mRNA vaccines and will likely issue full biologics licenses in the coming months.
Gostin, Lawrence O. +2 more
openaire +3 more sources
COVID-19 vaccine hesitancy [PDF]
Nature Reviews Nephrology, 2022 The COVID-19 pandemic has highlighted the vital role of vaccination in preventing life-threatening diseases and improving global health. Understanding and addressing the concerns of vaccine-hesitant individuals, including those with chronic diseases, is key to increasing vaccine acceptance and uptake.
Dubé, Eve, MacDonald, Noni E.
openaire +4 more sources
Clinical and Experimental Immunology, 2020 SummarySince the emergence of COVID-19, caused by the SARS-CoV-2 virus at the end of 2019, there has been an explosion of vaccine development. By 24 September 2020, a staggering number of vaccines (more than 200) had started preclinical development, of which 43 had entered clinical trials, including some approaches that have not previously been ...
Tregoning, J. S. +9 more
openaire +4 more sources
COVID‐19: vaccine’s progress [PDF]
Microbial Biotechnology, 2021 Summary Under the pressure of the COVID‐19 pandemic, vaccines were developed and rolled out into mass vaccination campaigns at incredible speed. What normally takes a decade was worked out within a year. Vaccines were produced along many different platforms ranging from inactivated whole virus vaccines over adenovirus‐vectored ...
openaire +4 more sources
COVID-19 vaccination passports [PDF]
Science, 2021 As countries grow eager to reignite their economies and people increasingly yearn for mobility and normalcy in life, pressure is mounting for some form of COVID-19 health status certificate that would support these desires. There has already been an explosion of COVID-19 passport initiatives for domestic use and international travel.
Dye, C, Mills, MC
openaire +2 more sources
COVID-19 vaccines and vaccine administration [PDF]
British Journal of Nursing, 2021 This article provides an overview of current COVID-19 vaccines available within the UK, including their mode of action, storage and handling. It outlines the recommendations on priority groups for vaccination and provides insight into the training recommendations for vaccinators.
Gordon, Charlotte +2 more
openaire +2 more sources
Annals of Clinical Microbiology and Antimicrobials, 2022 Background New vaccines are being developed to fight the ongoing COVID-19 pandemic. In our study we compared the efficacy of COVID-19 vaccines to prevent COVID-19-related infections and mortality.
Marharyta Sobczak, Rafał Pawliczak
doaj +1 more source